Skip to main content
. 2013 Aug 6;2(3):56–76. doi: 10.5527/wjn.v2.i3.56

Table 2.

Development of Shiga-toxin-associated hemolytic uremic syndrome

Pathogenetic steps Clinical
Ingestion of Escherichia Coli through contaminated food or patient to patient transmission or transmission from animal to man Colonization of the gut
Diarrhoea Local tissue damage
Bloody diarrhoea Systemic toxinemia
Generation of host cytokines and chemokines Endothelia cell damage, activation of local thrombosis in kidneys and in other organs
Renal involvement→ HUS Damage to glomerular endothelial cells, arteriolar damage, mesangial cell activation/damage, podocyte injury, tubular damage
Renal Insufficiency Acute renal failure
Chronic renal failure
Arterial hypertension, proteinuria, hematuria

HUS: Hemolytic uremic syndrome.